GINA CATANESE: Open Payments
NPI 1568954857 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 13 payments from 9 companies in 2025. Trend: 2023 $172 · 2024 $78 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Insmed, Inc. | 2 | $35 |
| INOGEN, INC. | 1 | $33 |
| Viatris Specialty LLC | 1 | $22 |
| Verona Pharma, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| GENZYME CORPORATION | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: Arikayce, DUPIXENT, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, TEZSPIRE, YUPELRI, Ohtuvayre, FASENRA, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
